{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T06:18:53Z","timestamp":1774073933385,"version":"3.50.1"},"reference-count":36,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,4,1]]},"abstract":"<jats:sec><jats:title>BACKGROUND:<\/jats:title><jats:p>Inhaled nitric oxide (iNO) therapy is an off-label medication in infants &amp;lt;34 weeks\u2019 gestational age. In 2011, the National Institutes of Health released a statement discouraging routine iNO use in premature infants. The objective of this study was to describe utilization patterns of iNO in American NICUs in the years surrounding the release of the National Institutes of Health statement. We hypothesized that iNO prescription rates in premature infants have remained unchanged since 2011.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS:<\/jats:title><jats:p>The Pediatrix Medical Group Clinical Data Warehouse was queried for the years 2009\u20132013 to describe first exposure iNO use among all admitted neonates stratified by gestational age.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS:<\/jats:title><jats:p>Between 2009 and 2013, the rate of iNO utilization in 23- to 29-week neonates increased from 5.03% to 6.19%, a relative increase of 23% (confidence interval: 8%\u201340%; P = .003). Of all neonates who received iNO therapy in 2013, nearly half were &amp;lt;34 weeks\u2019 gestation, with these infants accounting for more than half of all first exposure iNO days each year of the study period.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS:<\/jats:title><jats:p>The rates of off-label iNO use in preterm infants continue to rise despite evidence revealing no clear benefit in this population. This pattern of iNO prescription is not benign and comes with economic consequences.<\/jats:p><\/jats:sec>","DOI":"10.1542\/peds.2014-3290","type":"journal-article","created":{"date-parts":[[2015,3,10]],"date-time":"2015-03-10T00:32:23Z","timestamp":1425947543000},"page":"643-648","source":"Crossref","is-referenced-by-count":67,"title":["Off-Label Use of Inhaled Nitric Oxide After Release of NIH Consensus Statement"],"prefix":"10.1542","volume":"135","author":[{"given":"Marc A.","family":"Ellsworth","sequence":"first","affiliation":[{"name":"Division of Neonatal Medicine, Mayo Clinic, Rochester, Minnesota; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malinda N.","family":"Harris","sequence":"additional","affiliation":[{"name":"Division of Neonatal Medicine, Mayo Clinic, Rochester, Minnesota; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William A.","family":"Carey","sequence":"additional","affiliation":[{"name":"Division of Neonatal Medicine, Mayo Clinic, Rochester, Minnesota; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan R.","family":"Spitzer","sequence":"additional","affiliation":[{"name":"Center for Research, Education and Quality, Pediatrix Medical Group, Sunrise, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reese H.","family":"Clark","sequence":"additional","affiliation":[{"name":"Center for Research, Education and Quality, Pediatrix Medical Group, Sunrise, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2015,4,1]]},"reference":[{"issue":"9","key":"2021120907060872000_B1","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1056\/NEJM199702273360901","article-title":"Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure.","volume":"336","author":"Neonatal Inhaled Nitric Oxide Study Group","year":"1997","journal-title":"N Engl J Med"},{"issue":"7","key":"2021120907060872000_B2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1056\/NEJM200002173420704","article-title":"Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn.","volume":"342","author":"Clark","year":"2000","journal-title":"N Engl J Med"},{"issue":"4","key":"2021120907060872000_B3","first-page":"CD000399","article-title":"Nitric oxide for respiratory failure in infants born at or near term.","author":"Finer","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"2021120907060872000_B4","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM199702273360902","article-title":"Inhaled nitric oxide and persistent pulmonary hypertension of the newborn.","volume":"336","author":"Roberts","year":"1997","journal-title":"N Engl J Med"},{"issue":"12","key":"2021120907060872000_B5","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/jp.2010.37","article-title":"The changing pattern of inhaled nitric oxide use in the neonatal intensive care unit.","volume":"30","author":"Clark","year":"2010","journal-title":"J Perinatol"},{"issue":"3","key":"2021120907060872000_B6","doi-asserted-by":"crossref","first-page":"F191","DOI":"10.1136\/fn.77.3.F191","article-title":"Changes in oxygenation and pulmonary haemodynamics in preterm infants treated with inhaled nitric oxide.","volume":"77","author":"Subhedar","year":"1997","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"9184","key":"2021120907060872000_B7","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0140-6736(99)03558-8","article-title":"Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomised controlled trial.","volume":"354","author":"Kinsella","year":"1999","journal-title":"Lancet"},{"key":"2021120907060872000_B8","first-page":"S469","article-title":"Inhaled nitric oxide therapy in premature infants with mild to moderate respiratory distress syndrome.","volume":"85","author":"Srisuparp","year":"2002","journal-title":"J Med Assoc Thai"},{"issue":"22","key":"2021120907060872000_B9","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa031154","article-title":"Inhaled nitric oxide in premature infants with the respiratory distress syndrome.","volume":"349","author":"Schreiber","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"2021120907060872000_B10","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1542\/peds.2004-1209","article-title":"Neonatal Ventilation With Inhaled Nitric Oxide Versus Ventilatory Support Without Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure: the INNOVO multicentre randomised controlled trial (ISRCTN 17821339).","volume":"115","author":"Field","year":"2005","journal-title":"Pediatrics"},{"issue":"1","key":"2021120907060872000_B11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa043927","article-title":"Inhaled nitric oxide for premature infants with severe respiratory failure.","volume":"353","author":"Van Meurs","year":"2005","journal-title":"N Engl J Med"},{"issue":"3","key":"2021120907060872000_B12","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jpeds.2004.10.019","article-title":"The safety and efficacy of nitric oxide therapy in premature infants.","volume":"146","author":"Hascoet","year":"2005","journal-title":"J Pediatr"},{"issue":"9","key":"2021120907060872000_B13","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1080\/08035250600702594","article-title":"Inhaled nitric oxide in very preterm infants with severe respiratory distress syndrome.","volume":"95","author":"Dani","year":"2006","journal-title":"Acta Paediatr"},{"issue":"4","key":"2021120907060872000_B14","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa060442","article-title":"Early inhaled nitric oxide therapy in premature newborns with respiratory failure.","volume":"355","author":"Kinsella","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"2021120907060872000_B15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1056\/NEJMoa061088","article-title":"Inhaled nitric oxide in preterm infants undergoing mechanical ventilation.","volume":"355","author":"Ballard","year":"2006","journal-title":"N Engl J Med"},{"issue":"9738","key":"2021120907060872000_B16","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0140-6736(10)60664-2","article-title":"Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trial.","volume":"376","author":"Mercier","year":"2010","journal-title":"Lancet"},{"issue":"4","key":"2021120907060872000_B17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1542\/peds.2010-2725","article-title":"Inhaled nitric oxide in preterm infants: an individual-patient data meta-analysis of randomized trials.","volume":"128","author":"Askie","year":"2011","journal-title":"Pediatrics"},{"issue":"12","key":"2021120907060872000_B18","first-page":"CD000509","article-title":"Inhaled nitric oxide for respiratory failure in preterm infants.","author":"Barrington","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2021120907060872000_B19","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2010-3428","article-title":"Inhaled nitric oxide in preterm infants: a systematic review.","volume":"127","author":"Donohue","year":"2011","journal-title":"Pediatrics"},{"issue":"5","key":"2021120907060872000_B20","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1542\/peds.2009-0114","article-title":"Clinical and economic effects of iNO in premature newborns with respiratory failure at 1 year.","volume":"124","author":"Watson","year":"2009","journal-title":"Pediatrics"},{"issue":"11","key":"2021120907060872000_B21","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/jp.2013.75","article-title":"Therapeutic interventions and short-term outcomes for infants with severe bronchopulmonary dysplasia born at &lt;32 weeks\u2019 gestation.","volume":"33","author":"Padula","year":"2013","journal-title":"J Perinatol"},{"issue":"2","key":"2021120907060872000_B22","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1542\/peds.2010-3507","article-title":"NIH Consensus Development Conference statement: inhaled nitric-oxide therapy for premature infants.","volume":"127","author":"Cole","year":"2011","journal-title":"Pediatrics"},{"issue":"1","key":"2021120907060872000_B23","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1542\/peds.2013-3444","article-title":"Use of inhaled nitric oxide in preterm infants.","volume":"133","author":"Kumar","year":"2014","journal-title":"Pediatrics"},{"issue":"11","key":"2021120907060872000_B24","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/jp.2014.105","article-title":"Inhaled nitric oxide usage in preterm infants in the NICHD neonatal research network: inter-site variation and propensity evaluation.","volume":"34","author":"Truog","year":"2014","journal-title":"J Perinatol"},{"issue":"1","key":"2021120907060872000_B25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clp.2010.01.016","article-title":"The Pediatrix BabySteps Data Warehouse and the Pediatrix QualitySteps improvement project system\u2014tools for \u201cmeaningful use\u201d in continuous quality improvement.","volume":"37","author":"Spitzer","year":"2010","journal-title":"Clin Perinatol"},{"issue":"6","key":"2021120907060872000_B26","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1542\/peds.2005-1707","article-title":"Reported medication use in the neonatal intensive care unit: data from a large national data set.","volume":"117","author":"Clark","year":"2006","journal-title":"Pediatrics"},{"issue":"1","key":"2021120907060872000_B27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1542\/peds.2005-0179","article-title":"Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death.","volume":"117","author":"Clark","year":"2006","journal-title":"Pediatrics"},{"issue":"1","key":"2021120907060872000_B28","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jpeds.2007.03.017","article-title":"Neurodevelopmental outcomes of premature infants with severe respiratory failure enrolled in a randomized controlled trial of inhaled nitric oxide.","volume":"151","author":"Hintz","year":"2007","journal-title":"J Pediatr"},{"issue":"2","key":"2021120907060872000_B29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0022-3476(97)70347-0","article-title":"Nitric oxide inhalation in infants with respiratory distress syndrome.","volume":"130","author":"Skimming","year":"1997","journal-title":"J Pediatr"},{"issue":"5","key":"2021120907060872000_B30","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/(SICI)1099-0496(199711)24:5<319::AID-PPUL3>3.0.CO;2-D","article-title":"Response of premature infants with severe respiratory failure to inhaled nitric oxide.","volume":"24","author":"Van Meurs","year":"1997","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"2021120907060872000_B31","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1055\/s-0028-1104743","article-title":"Inhaled nitric oxide for preterm premature rupture of membranes, oligohydramnios, and pulmonary hypoplasia.","volume":"26","author":"Chock","year":"2009","journal-title":"Am J Perinatol"},{"issue":"4","key":"2021120907060872000_B32","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1542\/peds.76.4.622","article-title":"Extracorporeal membrane oxygenation and the play the winner rule.","volume":"76","author":"Paneth","year":"1985","journal-title":"Pediatrics"},{"issue":"8739","key":"2021120907060872000_B33","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/0140-6736(91)93406-Y","article-title":"Neonatal extracorporeal membrane oxygenation: how not to assess novel technologies.","volume":"337","author":"Elliott","year":"1991","journal-title":"Lancet"},{"issue":"3","key":"2021120907060872000_B34","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/1089253209347948","article-title":"Extracorporeal membrane oxygenation for the treatment of neonatal respiratory failure.","volume":"13","author":"Carey","year":"2009","journal-title":"Semin Cardiothorac Vasc Anesth"},{"issue":"2","key":"2021120907060872000_B35","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2013-2644","article-title":"Inhaled nitric oxide use in neonates with congenital diaphragmatic hernia.","volume":"134","author":"Campbell","year":"2014","journal-title":"Pediatrics"},{"key":"2021120907060872000_B36","volume-title":"Births: Final Data for 2012. National Vital Statistics Reports","author":"Martin","year":"2013"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/135\/4\/643\/1061250\/peds_2014-3290.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/135\/4\/643\/1061250\/peds_2014-3290.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T19:34:59Z","timestamp":1651433699000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/135\/4\/643\/33556\/Off-Label-Use-of-Inhaled-Nitric-Oxide-After"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,1]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,4,1]]},"published-print":{"date-parts":[[2015,4,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2014-3290","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,1]]}}}